Mental Health Clinics in Swedesboro, NJ Accepting Medicare
9 Mental Health Clinics found. Showing 1 - 9
 Full Bloom Counseling Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 38 Stonemill Way, Swedesboro, NJ 08085 Phone: 609-202-1107 |
Pennsville Counseling Associates, L.l.c. Psychologist Medicare: Medicare Enrolled Practice Location: 545 Beckett Rd Ste 207, Swedesboro, NJ 08085 Phone: 856-467-1000 Fax: 856-467-1150 |
Bancroft Neurohealth- 104 Richardson Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 104 Richardson Ave, Swedesboro, NJ 08085 Phone: 800-774-5516 Fax: 856-429-4755 |
Path Toward Recovery, Llc Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 16 Bayberry Way, Swedesboro, NJ 08085 Phone: 732-216-3959 |
M Leyman Company Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1919 Kings Hwy Fl 2, Swedesboro, NJ 08085 Phone: 800-845-0336 Fax: 856-553-0662 |
Michelle Leyman & Associates Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1919 Kings Hwy Fl 2, Swedesboro, NJ 08085 Phone: 800-845-0336 Fax: 856-553-0662 |
Kelly Redkoles, Lcsw, Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 68 Paulsboro Rd, Swedesboro, NJ 08085 Phone: 856-889-5902 Fax: 856-889-5902 |
New Jersey Respite Care Plus, Llc Psychologist - Mental Retardation & Developmental Disabilities Medicare: Not Enrolled in Medicare Practice Location: 112 Arbor Dr, Swedesboro, NJ 08085 Phone: 609-337-5447 Fax: 609-337-5021 |
Rebuilding U Counseling Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1 Pond View Dr Apt E2, Swedesboro, NJ 08085 Phone: 856-397-9187 |
News Archive
US PTO grants new allowances to intellectual property covering Neurologix' GAD based delivery systems
Neurologix, Inc., a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced that the U.S. Patent and Trademark Office (US PTO) has expanded the intellectual property protections enabled by a previously issued patent that is central to Neurologix's Parkinson's disease program. The new allowances to U.S. Patent Number 765,446, entitled "Glutamic acid decarboxylase (GAD) based delivery systems," broaden the patent's coverage beyond Parkinson's disease to include the use of GAD65 in the treatment of other neurological and related disorders.
Potent inhibitor of Kinesin CENP-E demonstrates tumor cell inhibition
A first-in-class, targeted investigational therapy specifically designed to inhibit a single protein that functions only during cell division shows potent activity in a broad range of cancer cell lines, say researchers from GlaxoSmithKline.
RegeneRx RGN-352 Phase 2 trial in acute myocardial infarction placed on clinical hold
RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.
New algorithm analyzes weather patterns to predict yield and grain composition of corn
Corn is planted on approximately 90 million acres across the United States every year. With all that data, it takes months after harvest for government agencies to analyze total yield and grain quality.
Echinacea may have minimal impact in relieving common cold
An over-the-counter herbal treatment believed to have medicinal benefits has minimal impact in relieving the common cold, according to research by the University of Wisconsin-Madison School of Medicine and Public Health.
› Verified 9 days ago